Q3 Asset Management Gilead Sciences, Inc. Transaction History

Q3 Asset Management

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 28, 2023	BUY	$76.01 - $86.7 $740,793 - $844,978	9,746 Added 76.46%	22,493 $1.73 Million
Q1 2023 Apr 26, 2023	BUY	$77.31 - $88.08 $690,610 - $786,818	8,933 Added 234.22%	12,747 $1.06 Million
Q4 2022 Feb 02, 2023	BUY	$62.32 - $89.47 $237,688 - $341,238	3,814 New	3,814 $325,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Q3 Asset Management, based on Form 13F filings with the SEC.

Stay updated on Q3 Asset Management with notifications on news.